Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Deubiquitinating Enzymes Of The 19S Proteasome Offer Novel Therapeutic Opportunity In Bortezomib Resistant Waldenströms Macroglobulinemia

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Sharoon Akhtar, Maja Kuranz, Vivek Roy, M.D., Stephen M Ansell, M.D.Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Richard R. Furman, MD, Morton Coleman, MD, Stig Linder, MD, PhD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 4426.

https://doi.org/10.1182/blood.V122.21.4426.4426

Published: 2013

Journal Articles

A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma

Blood (2013) 122 (21): 1940.

https://doi.org/10.1182/blood.V122.21.1940.1940

Published: 2013

Journal Articles

Copy Number Abnormalities Of The Interferon Regulatory Factor-4 ( IRF4 ) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas

Rebecca L Boddicker, Ryan A Knudson, Rhett P Ketterling, Law E Mark, Xiaoming Xing, James R Cerhan, MD, PhD, Yanhong Wu, Julie M Cunningham, Stephen M Ansell, M.D.Ph.D., Andrew L. Feldman

Blood (2013) 122 (21): 3016.

https://doi.org/10.1182/blood.V122.21.3016.3016

Published: 2013

Journal Articles

Interference Of The Tumor Supportive Effects Of BCL2 and MCL1 Sensitize Malignant Plasma Cells To The Lethal Effects Of Lenalidomide and Dexamethasone Regimen: An Important Clinical Path For BCL2 Targeting Drugs

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Sharoon Akhtar, Maja Kuranz, Shaji Kumar, MD, Vivek Roy, MD, FACP, Stephen M. Ansell, M.D.Ph.D., Joseph R. Mikhael, MD, Angela Dispenzieri, MD, Craig Reeder, MD, Candido E. Rivera, MD, James M. Foran, MD, Francis Buadi, MD, Vincent Rajkumar, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 1928.

https://doi.org/10.1182/blood.V122.21.1928.1928

Published: 2013

Journal Articles

Tumor Monocyte Cross Talk Promotes Chemotherapy Resistance In Lymphoma

Zhe Zhang, Ph.D., Matthew J Maurer, MS, Peggy A Bulur, Gustafson P Michael, Ph.D., Thomas M Habermann, MD, Curtis L Olswold, James R Cerhan, MD, PhD, Brian K Link, MD, Dennis A. Gastineau, MD, Thomas E Witzig, MD, Stephen M Ansell, M.D.Ph.D., Allan B Dietz, PhD, Yi Lin, MDPhD

Blood (2013) 122 (21): 1774.

https://doi.org/10.1182/blood.V122.21.1774.1774

Published: 2013

Journal Articles

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Deanna M. Grote, Steven C. Ziesmer, Lucy S. Hodge, PharmD, Ph.D., Tammy L. Price-Troska, Anne J. Novak, Ph.D., Zhi-Zhang Yang, MD, Stephen M Ansell, M.D.Ph.D.

Blood (2013) 122 (21): 4334.

https://doi.org/10.1182/blood.V122.21.4334.4334

Published: 2013

Journal Articles

Heterogeneous Bcl-2 Family Expression In Waldenström Macroglobulinemia Determines Response To Inducers Of Intrinsic Apoptosis

Brian T Gaudette, Kasyapa S. Chitta, PhD, Stephanie Poulain, Kelvin P Lee, MD, Asher Chanan-Khan, MD, Stephen M Ansell, M.D.Ph.D., Xavier Leleu, MD, PhD, Sagar Lonial, M.D., Lawrence H. Boise, PhD

Blood (2013) 122 (21): 4287.

https://doi.org/10.1182/blood.V122.21.4287.4287

Published: 2013

Journal Articles

Inhibition Of The Deubiquitinating Enzymes UCHL5 and USP14 Is Lethal To Waldenströms Macroglobulinemia Cells

Kasyapa S. Chitta, PhD, Aneel Paulus, MD, MS, Sharoon Akhtar, Maja Kuranz, Vivek Roy, M.D., Stephen M Ansell, M.D.Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Richard R. Furman, MD, Morton Coleman, MD, Stig Linder, MD, PhD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 1823.

https://doi.org/10.1182/blood.V122.21.1823.1823

Published: 2013

Journal Articles

Three-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma

Ajay K. Gopal, MD, Robert Chen, MD, Scott E. Smith, MD, PhD, Stephen M Ansell, M.D.Ph.D., Joseph D Rosenblatt, MD, Kerry J. Savage, MD, MSc, Joseph M. Connors, MD, Andreas Engert, MD, Emily K. Larsen, MS, Dirk Huebner, MD, Eric L. Sievers, MD, Anas Younes, MD

Blood (2013) 122 (21): 4382.

https://doi.org/10.1182/blood.V122.21.4382.4382

Published: 2013

Journal Articles

PD-1 Expression Defines Two Distinct T-Cell Subpopulations That Differentially Impact Patient Outcomes In Follicular Lymphoma

Zhi-Zhang Yang, MD, Deanna M. Grote, Steven C. Ziesmer, Stephen M Ansell, M.D.Ph.D.

Blood (2013) 122 (21): 366.

https://doi.org/10.1182/blood.V122.21.366.366

Published: 2013

Journal Articles

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Tianjiao Wang, Ph.D., Andrew L. Feldman, David A Wada, MD, Ye Lu, MD, Avery Polk, BS, Robert Briski, BS, Kay M. Ristow, Thomas M Habermann, MD, Dafydd G Thomas, MD/Ph.D., Steven C. Ziesmer, Linda E Wellik, Thomas Lanigan, Ph.D., Thomas E Witzig, MD, Mark Pittelkow, MD, Nathanael G. Bailey, MD, Megan Lim, MD, PhD, Stephen M Ansell, M.D.Ph.D., Ryan A. Wilcox, MD, PhD

Blood (2013) 122 (21): 841.

https://doi.org/10.1182/blood.V122.21.841.841

Published: 2013

Journal Articles

A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

Blood (2013) 122 (21): 76.

https://doi.org/10.1182/blood.V122.21.76.76

Published: 2013

Journal Articles

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Sharoon Akhtar, Maja Kuranz, Paul K. Wallace, MS, PhD, Sikander Ailawadhi, M.D., Kena Miller, A.R.N.P, Candido E. Rivera, MD, Gerardo Colon-Otero, MD, Vivek Roy, M.D., Stephen M Ansell, M.D.Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Morton Coleman, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 5091.

https://doi.org/10.1182/blood.V122.21.5091.5091

Published: 2013

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

NARROW

The Deubiquitinating Enzymes Of The 19S Proteasome Offer Novel Therapeutic Opportunity In Bortezomib Resistant Waldenströms Macroglobulinemia

A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma

Copy Number Abnormalities Of The Interferon Regulatory Factor-4 ( IRF4 ) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas

Interference Of The Tumor Supportive Effects Of BCL2 and MCL1 Sensitize Malignant Plasma Cells To The Lethal Effects Of Lenalidomide and Dexamethasone Regimen: An Important Clinical Path For BCL2 Targeting Drugs

Tumor Monocyte Cross Talk Promotes Chemotherapy Resistance In Lymphoma

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Heterogeneous Bcl-2 Family Expression In Waldenström Macroglobulinemia Determines Response To Inducers Of Intrinsic Apoptosis

Inhibition Of The Deubiquitinating Enzymes UCHL5 and USP14 Is Lethal To Waldenströms Macroglobulinemia Cells

Three-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma

PD-1 Expression Defines Two Distinct T-Cell Subpopulations That Differentially Impact Patient Outcomes In Follicular Lymphoma

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only